Fig. 4From: Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AMLAll proteomic signatures selected from ex vivo modeling cluster MOLM13 parental cell lines from those that are resistant to trametinib. A Heatmap of signature selected from LASSO regression. B Heatmap of signature selected from ElasticNet. C Heatmap of signature selected from logistic regression. D LegendBack to article page